These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34048765)

  • 1. Trimodality Approach for Esophageal Malignancies.
    Watkins AA; Zerillo JA; Kent MS
    Surg Clin North Am; 2021 Jun; 101(3):453-465. PubMed ID: 34048765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant chemoradiation is associated with improved overall survival in older patients with esophageal cancer.
    Guttmann DM; Mitra N; Metz JM; Plastaras J; Feng W; Swisher-McClure S
    J Geriatr Oncol; 2018 Jan; 9(1):40-46. PubMed ID: 28887066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low- vs. High-Dose Neoadjuvant Radiation in Trimodality Treatment of Locally Advanced Esophageal Cancer.
    Ji KSY; Thomas SM; Roman SA; Czito B; Anderson KL; Frakes J; Adam MA; Sosa JA; Robinson TJ
    J Gastrointest Surg; 2019 May; 23(5):885-894. PubMed ID: 30374818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current choices and prospects in management of postoperative esophageal cancer patients.
    Tu CC; Hsu PK
    Asian J Surg; 2019 Jan; 42(1):81-84. PubMed ID: 30121147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cT
    Tang H; Tan L; Shen Y; Wang H; Lin M; Feng M; Xu S; Guo W; Qian C; Liu T; Zeng Z; Hou Y; Yu Z; Jiang H; Li Z; Chen C; Lian C; Du M; Li H; Xie D; Yin J; Zhao N; Wang Q
    BMC Cancer; 2017 Jun; 17(1):450. PubMed ID: 28659128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of Adjuvant Chemotherapy After Neoadjuvant Chemoradiation and Esophagectomy for Esophageal Cancer.
    Burt BM; Groth SS; Sada YH; Farjah F; Cornwell L; Sugarbaker DJ; Massarweh NN
    Ann Surg; 2017 Aug; 266(2):297-304. PubMed ID: 27501170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant chemotherapy or chemoradiotherapy for locally advanced esophageal cancer.
    Smithers BM; Thomson I
    Thorac Surg Clin; 2013 Nov; 23(4):509-23. PubMed ID: 24199701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival based on pathologic response to neoadjuvant therapy in esophageal cancer.
    Tiesi G; Park W; Gunder M; Rubio G; Berger M; Ardalan B; Livingstone A; Franceschi D
    J Surg Res; 2017 Aug; 216():65-72. PubMed ID: 28807215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Definitive chemoradiotherapy for esophageal carcinoma.
    Cooper SL; Russo JK; Chin S
    Surg Clin North Am; 2012 Oct; 92(5):1213-48. PubMed ID: 23026279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective comparison of neoadjuvant chemoradiotherapy regimens for locally advanced esophageal cancer.
    Sanford NN; Catalano PJ; Enzinger PC; King BL; Bueno R; Martin NE; Hong TS; Wo JY; Mamon HJ
    Dis Esophagus; 2017 Jul; 30(7):1-8. PubMed ID: 28475728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of trimodality CROSS regimen in older adults with locally advanced esophageal cancer.
    Cooper L; Dezube AR; De León LE; Kucukak S; Mazzola E; Dumontier C; Mamon H; Enzinger P; Jaklitsch MT; Frain LN; Wee JO
    Eur J Surg Oncol; 2021 Oct; 47(10):2667-2674. PubMed ID: 33895020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of advanced-stage operable esophageal cancer.
    Bharat A; Crabtree T
    Surg Clin North Am; 2012 Oct; 92(5):1179-97. PubMed ID: 23026277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term Treatment Outcomes for Locally Advanced Esophageal Cancer: A Single-Institution Experience.
    Sio TT; Wilson ZC; Stauder MC; Bhatia S; Martenson JA; Quevedo JF; Schomas DA; Miller RC
    Am J Clin Oncol; 2016 Oct; 39(5):448-52. PubMed ID: 24879469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoradiation for esophageal cancer.
    Blum MA; Taketa T; Sudo K; Wadhwa R; Skinner HD; Ajani JA
    Thorac Surg Clin; 2013 Nov; 23(4):551-8. PubMed ID: 24199704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New therapeutic strategies for squamous cell cancer and adenocarcinoma.
    Wijnhoven BPL; Toxopeus ELA; Vallböhmer D; Knoefel WT; Krasna MJ; Perez K; van Rossum PSN; Ruurda JP; van Hillegersberg R; Schiesser M; Schneider P; Felix VN
    Ann N Y Acad Sci; 2013 Oct; 1300():213-225. PubMed ID: 24117644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization of surgery in trimodality-eligible patients with locally advanced esophageal adenocarcinoma in a nonprotocol setting.
    Murphy CC; Hofstetter WL; Correa AM; Ajani JA; Komaki RU; Swisher SG
    Dis Esophagus; 2013; 26(7):708-15. PubMed ID: 23350713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant Therapies for Esophageal Cancer.
    Abdelhakeem A; Blum Murphy M
    Thorac Surg Clin; 2022 Nov; 32(4):457-465. PubMed ID: 36266033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of radiation pneumonitis in patients receiving taxane-based trimodality therapy for locally advanced esophageal cancer.
    Shaikh T; Churilla TM; Monpara P; Scott WJ; Cohen SJ; Meyer JE
    Pract Radiat Oncol; 2016; 6(6):388-394. PubMed ID: 27025161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined Modality Therapy for Management of Esophageal Cancer: Current Approach Based on Experiences from East and West.
    Moaven O; Wang TN
    Surg Clin North Am; 2019 Jun; 99(3):479-499. PubMed ID: 31047037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance Following Treatment of Esophageal Cancer.
    Bakhos CT; Acevedo E; Petrov RV; Abbas AE
    Surg Clin North Am; 2021 Jun; 101(3):499-509. PubMed ID: 34048769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.